Identification of Minimal Antigenic Domains In HIV-1 Envelope Glycoprotein Recognized by Broadly Neutralizing Monoclonal Antibodies VRC01 And PG9

被引：0
|
作者：
Wang, H. [1 ]
Shi, X. [1 ]
Yao, C. [1 ]
Zuo, T. [1 ]
Zhang, L. [1 ]
机构：
[1] Tsinghua Univ, AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2011年 / 27卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [1] Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
    Li, Yuxing
    O'Dell, Sijy
    Walker, Laura M.
    Wu, Xueling
    Guenaga, Javier
    Feng, Yu
    Schmidt, Stephen D.
    McKee, Krisha
    Louder, Mark K.
    Ledgerwood, Julie E.
    Graham, Barney S.
    Haynes, Barton F.
    Burton, Dennis R.
    Wyatt, Richard T.
    Mascola, John R.
    JOURNAL OF VIROLOGY, 2011, 85 (17) : 8954 - 8967
  • [2] V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
    D Guo
    X Shi
    K Arledge
    D Song
    L Jiang
    L Fu
    S Zhang
    X Wang
    L Zhang
    Retrovirology, 9 (Suppl 2)
  • [3] V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
    Guo, D.
    Shi, X.
    Arledge, K.
    Song, D.
    Jiang, L.
    Fu, L.
    Zhang, S.
    Wang, X.
    Zhang, L.
    RETROVIROLOGY, 2012, 9
  • [4] Combined HIV-1 Neutralization Coverage by VRC01, PG9, and PG16
    Doria-Rose, N. A.
    Wu, X.
    Yang, Z.
    Louder, M. K.
    McKee, K.
    O'Dell, S.
    Schmidt, S.
    Koff, W. C.
    Seaman, M. S.
    Bailer, R.
    Burton, D. R.
    Mascola, J. R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A48 - A48
  • [5] Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features
    Juraska, Michal
    Bai, Hongjun
    deCamp, Allan C.
    Magaret, Craig A.
    Li, Li
    Gillespie, Kevin
    Carpp, Lindsay N.
    Giorgi, Elena E.
    Ludwig, James
    Molitor, Cindy
    Hudson, Aaron
    Williamson, Brian D.
    Espy, Nicole
    Simpkins, Brian
    Rudnicki, Erika
    Shao, Danica
    Rossenkhan, Raabya
    Edlefsen, Paul T.
    Westfall, Dylan H.
    Deng, Wenjie
    Chen, Lennie
    Zhao, Hong
    Bhattacharya, Tanmoy
    Pankow, Alec
    Murrell, Ben
    Yssel, Anna
    Matten, David
    York, Talita
    Beaume, Nicolas
    Gwashu-Nyangiwe, Asanda
    Ndabambi, Nonkululeko
    Thebus, Ruwayhida
    Karuna, Shelly T.
    Morris, Lynn
    Montefiori, David C.
    Hural, John A.
    Cohen, Myron S.
    Corey, Lawrence
    Rolland, Morgane
    Gilbert, Peter B.
    Williamson, Carolyn
    Mullins, James I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (04)
  • [6] Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults
    Huang, Yunda
    Zhang, Lily
    Ledgerwood, Julie
    Grunenberg, Nicole
    Bailer, Robert
    Isaacs, Abby
    Seaton, Kelly
    Mayer, Kenneth H.
    Capparelli, Edmund
    Corey, Larry
    Gilbert, Peter B.
    MABS, 2017, 9 (05) : 792 - 800
  • [7] Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic
    Euler, Zelda
    Bunnik, Evelien M.
    Burger, Judith A.
    Boeser-Nunnink, Brigitte D. M.
    Grijsen, Marlous L.
    Prins, Jan M.
    Schuitemaker, Hanneke
    JOURNAL OF VIROLOGY, 2011, 85 (14) : 7236 - 7245
  • [8] Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
    RM Lynch
    L Tran
    X Wu
    Y Li
    B Lee
    J Mascola
    Retrovirology, 9
  • [9] Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
    Ledgerwood, J. E.
    Coates, E. E.
    Yamshchikov, G.
    Saunders, J. G.
    Holman, L.
    Enama, M. E.
    DeZure, A.
    Lynch, R. M.
    Gordon, I.
    Plummer, S.
    Hendel, C. S.
    Pegu, A.
    Conan-Cibotti, M.
    Sitar, S.
    Bailer, R. T.
    Narpala, S.
    McDermott, A.
    Louder, M.
    O'Dell, S.
    Mohan, S.
    Pandey, J. P.
    Schwartz, R. M.
    Hu, Z.
    Koup, R. A.
    Capparelli, E.
    Mascola, J. R.
    Graham, B. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (03): : 289 - 301
  • [10] Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
    Lynch, R. M.
    Tran, L.
    Wu, X.
    Li, Y.
    Lee, B.
    Mascola, J.
    RETROVIROLOGY, 2012, 9
12345